Skip to main content

DV 125 (Divalproex Sodium Delayed-Release (Sprinkle) 125 mg)

Pill with imprint DV 125 is Blue & White, Capsule-shape and has been identified as Divalproex Sodium Delayed-Release (Sprinkle) 125 mg. It is supplied by Ajanta Pharma Limited.

Divalproex sodium is used in the treatment of bipolar disorder; mania; migraine prevention; epilepsy and belongs to the drug class fatty acid derivative anticonvulsants. When treating epilepsy and manic episodes associated with bipolar disorder: There is positive evidence of human fetal risk during pregnancy. When treating migraine: Not for use in pregnancy. Divalproex sodium 125 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DV 125

Divalproex sodium delayed-release (sprinkle) 125 mg DV 125

Divalproex Sodium Delayed-Release (Sprinkle)

DV 125
125 mg
Blue & White
Prescription only
Drug Class
Fatty acid derivative anticonvulsants
Pregnancy Category
D - Positive evidence of risk - When treating epilepsy and manic episodes associated with bipolar disorder, X - Not for use in pregnancy - When treating migraine
CSA Schedule
Not a controlled drug
Labeler / Supplier
Ajanta Pharma Limited
National Drug Code (NDC)

Get help with Imprint Code FAQs.

Related Images for "DV 125"

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.